Ponatinix (Ponatinib) 15 MG – 30 TABLETS

$450.00

Ponatinix(Ponatinib) indicate for the treatment of patients with chronic phase, accelerated phase, or blast phase chronic myeloid leukemia (CML) that is resistant or intolerant to prior tyrosine kinase inhibitor therapy or Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ALL) that is resistant or intolerant to prior tyrosine kinase inhibitor therapy.

whatsapp_qr
Whatsapp +8801922101029